Publications

Publications From: Matthew R. Reynolds, M.D, M.Sc.

Current clinical characteristics and economic impact of subacute stent thrombosis. J Invasive Cardiol. 2002 Jul;14(7):364-8.

Quality of Life in Atrial Fibrillation: Measurement Tools and Impact of Interventions. J Cardiovasc Electrophysiol. 2008 Feb 4

Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007 Dec 27;357(26):2657-65.

Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. Am J Cardiol. 2003;92(6):677-81.

Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation:.... Am Heart J. 2006 Dec;152(6):1097-103.

Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol. 2007 Jun;18(6):628-33.

Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. 2007 Aug 13-27;167(15):1648-53.

Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol. 2006 Feb 15;97(4):538-43.

The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006 Jun 20;47(12):2493-7.